Invention Grant
- Patent Title: Recombinant lactic acid bacteria and the use thereof in oral universal influenza vaccine
-
Application No.: US15777672Application Date: 2016-11-21
-
Publication No.: US10851136B2Publication Date: 2020-12-01
- Inventor: Chung Yan Shum , Tak Keung Andy Wong
- Applicant: CREATION PLUS BIOTECHNOLOGY CO. LTD
- Applicant Address: HK Hong Kong
- Assignee: CREATION PLUS BIOTECHNOLOGY CO. LTD
- Current Assignee: CREATION PLUS BIOTECHNOLOGY CO. LTD
- Current Assignee Address: HK Hong Kong
- Agency: Idea Intellectual Limited
- Agent Margaret A. Burke; Sam T. Yip
- International Application: PCT/CN2016/106690 WO 20161121
- International Announcement: WO2017/084635 WO 20170526
- Main IPC: C07K14/005
- IPC: C07K14/005 ; C07K14/205 ; A61K39/12 ; C07K14/285 ; A61K39/145 ; C07K14/435 ; A61K39/00
Abstract:
The present invention relates to an oral universal influenza vaccine comprising recombinant lactic acid bacteria which express proteins including but not limited to ferritin protein plus highly-conserved stem fragment of hemagglutinin (HA) proteins expressed in all known influenza viruses. The present invention also relates to the recombinant protein comprising the highly-conserved stem fragment of HA and ferritin proteins.
Public/Granted literature
- US20180334481A1 RECOMBINANT LACTIC ACID BACTERIA AND THE USE THEREOF IN ORAL UNIVERSAL INFLUENZA VACCINE Public/Granted day:2018-11-22
Information query
